[go: up one dir, main page]

DE68913737D1 - Neue o-(3-amino-2-hydroxypropyl)-hydroximsäurehalogenide und verfahren zur herstellung derselben. - Google Patents

Neue o-(3-amino-2-hydroxypropyl)-hydroximsäurehalogenide und verfahren zur herstellung derselben.

Info

Publication number
DE68913737D1
DE68913737D1 DE89911590T DE68913737T DE68913737D1 DE 68913737 D1 DE68913737 D1 DE 68913737D1 DE 89911590 T DE89911590 T DE 89911590T DE 68913737 T DE68913737 T DE 68913737T DE 68913737 D1 DE68913737 D1 DE 68913737D1
Authority
DE
Germany
Prior art keywords
hydroxypropyl
amino
new
production
hydroximic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE89911590T
Other languages
English (en)
Other versions
DE68913737T2 (de
Inventor
Nagy Peter Literati
Bela Balazs
Maria Boross
Jenoe Szilbereky
Gizella Zsila
Lajos Abraham
Gyoergy Blasko
Bela Gachalyi
Attila Almasi
Gabor Nemeth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LadRx Corp
Original Assignee
Biorex Kutato Fejleszto Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejleszto Kft filed Critical Biorex Kutato Fejleszto Kft
Publication of DE68913737D1 publication Critical patent/DE68913737D1/de
Application granted granted Critical
Publication of DE68913737T2 publication Critical patent/DE68913737T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/08—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
DE68913737T 1988-10-20 1989-10-19 Neue o-(3-amino-2-hydroxypropyl)-hydroximsäurehalogenide und verfahren zur herstellung derselben. Expired - Lifetime DE68913737T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU885405A HU207988B (en) 1988-10-20 1988-10-20 Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
PCT/HU1989/000048 WO1990004584A1 (en) 1988-10-20 1989-10-19 Novel o-(3-amino-2-hydroxypropyl)-hydroximic acid halides and process for preparing the same

Publications (2)

Publication Number Publication Date
DE68913737D1 true DE68913737D1 (de) 1994-04-14
DE68913737T2 DE68913737T2 (de) 1994-07-28

Family

ID=10970243

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68913737T Expired - Lifetime DE68913737T2 (de) 1988-10-20 1989-10-19 Neue o-(3-amino-2-hydroxypropyl)-hydroximsäurehalogenide und verfahren zur herstellung derselben.

Country Status (20)

Country Link
US (3) US5147879A (de)
EP (1) EP0417210B1 (de)
JP (1) JPH0819078B2 (de)
KR (1) KR0154117B1 (de)
AU (1) AU620460B2 (de)
CA (1) CA2000830C (de)
DE (1) DE68913737T2 (de)
DK (1) DK175584B1 (de)
ES (1) ES2020030A6 (de)
FI (1) FI93214C (de)
GR (1) GR1002253B (de)
HU (1) HU207988B (de)
IE (1) IE65113B1 (de)
IL (1) IL92000A (de)
NO (1) NO178148C (de)
PL (1) PL164547B1 (de)
PT (1) PT92041B (de)
RU (1) RU2093508C1 (de)
UA (1) UA34412C2 (de)
WO (1) WO1990004584A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE170170T1 (de) * 1994-05-06 1998-09-15 Biorex Kutato Fejlesztoe Kft Hydroximsäurederivate, diese enthaltende pharmazeutische zubereitungen und verfahren zu deren herstellung
US5665756A (en) * 1994-08-03 1997-09-09 Hoechst Marion Roussel, Inc. Aminoalkyloximes useful in the treatment of depression and obsessive compulsive disorders
HU9502843D0 (en) * 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
US6884424B2 (en) 1995-12-22 2005-04-26 N-Gene Research Laboratories Inc. Method for treating the pathological lesions of the skin that develop by ultraviolet radiation of the sunlight
HUT78138A (hu) * 1995-12-22 2000-09-28 BIOREX Kutató és Fejlesztő Rt Hidroximsavszármazékot tartalmazó készítmény a növénytermesztés elősegítésére és alkalmazása
AU745987B2 (en) * 1995-12-22 2002-04-11 N-Gene Research Laboratories Inc. A cosmetic composition and a method for reducing the ageing processes of skin
US6458371B1 (en) 1995-12-22 2002-10-01 Medgene, Limited Cosmetic composition and a method for the prevention and/or reduction of the photoaging processes of the skin
HUT78139A (hu) * 1995-12-22 2000-11-28 BIOREX Kutató és Fejlesztő Rt. Készítmény, különösen a bőr öregedési folyamatainak mérséklésére
DE19607960A1 (de) * 1996-03-01 1997-09-04 Hoechst Schering Agrevo Gmbh Verfahren zur Herstellung von Ketonoximether durch Boronsäurekupplung
GB9613339D0 (en) * 1996-06-26 1996-08-28 Kritzinger Ann C Limp bookbinding assembly technique for two books in one pass
UA64716C2 (en) * 1996-08-09 2004-03-15 Pharmaceuticals for therapy or prevention of illnesses connected with dysfunction of vascular endothelial cells
HU220971B1 (hu) * 1997-04-03 2002-07-29 BIOREX Kutató és Fejlesztő Rt. Eljárás 0-(3-amino-2-hidroxi-propil)-hidroximsav-halogenidek előállítására
HU9701081D0 (en) 1997-06-23 1997-08-28 Gene Research Lab Inc N Pharmaceutical composition of antitumoral activity
WO2000007580A2 (en) * 1998-08-03 2000-02-17 N-Gene Kutató Kft. Pharmaceutical compositions against autoimmune diseases
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
US6933104B1 (en) 1999-04-23 2005-08-23 Shiva Biomedical, Llc Diagnosis and treatment of human kidney diseases
HUP0001583A2 (hu) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
DK1408966T3 (da) * 2001-07-17 2008-06-16 N Gene Res Lab Inc Synergistiske farmaceutiske kombinationer til forebyggelse eller behandling af diabetes
HUP0105205A2 (hu) * 2001-11-29 2003-08-28 BIOREX Kutató és Fejlesztő Rt. Metformint és egy hidroxilaminszármazékot tartalmazó, gyógyászati készítmény
CN1279889C (zh) * 2001-12-21 2006-10-18 罗迪亚公司 稳定混合的阳离子和阴离子表面活性剂组合物
AU2003202104B8 (en) * 2002-01-11 2008-10-02 Cytrx Corporation Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) * 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
DE10351448A1 (de) * 2003-11-04 2005-06-09 Bayer Healthcare Ag Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften
US20080227813A1 (en) * 2006-09-26 2008-09-18 Jack Raymond Barber Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
US7763601B2 (en) * 2006-11-02 2010-07-27 N-Gene Research Laboratories, Inc. Prevention and treatment of obesity
EA201100805A1 (ru) 2008-11-18 2011-10-31 Сантен Фармасьютикал Ко., Лтд. Терапевтический агент при хориоретинальном дегенеративном заболевании, содержащий в качестве активного ингредиента производное пиридин-3-карбальдегид-o-(пиперидин-1-илпропил)оксима
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
BR112020005732A2 (pt) 2017-09-22 2020-10-27 The University Of Adelaide métodos e produtos para melhorar a qualidade de espermatozoides
KR101995300B1 (ko) 2018-03-30 2019-10-17 주식회사 아세아텍 다목적 관리기용 작업기 탈부착장치
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
CN112174853B (zh) * 2020-11-03 2023-07-25 湖南经世新材料有限责任公司 一种氨解法制备（z）-n-羟基苯脒的方法
KR20230128462A (ko) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 아리모클로몰 시트레이트 및 이의 중간체를 제조하기 위한 공정
KR20240070616A (ko) * 2021-09-28 2024-05-21 제브라 덴마크 에이/에스 옥심 및 gba 관련 질환의 치료에서의 이의 용도
AU2023454616A1 (en) 2023-07-10 2026-01-22 N-Gene Research Laboratories, Inc. Increasing telomere length and/or suppressing telomere shortening

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670497C3 (de) * 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung
HU177578B (en) * 1976-08-27 1981-11-28 Chinoin Gyogyszer Es Vegyeszet Process for preparing new 0-/3-amino-2-hydroxy-propyl/-amidoxime derivatives
US4187220A (en) * 1977-08-30 1980-02-05 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. New O-(3-amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
US4308399A (en) * 1977-08-30 1981-12-29 Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. O-(3-Amino-2-hydroxy-propyl)-amidoxime derivatives, process for the preparation thereof and pharmaceutical compositions containing same
EP0369944A1 (de) * 1988-11-18 1990-05-23 Ciba-Geigy Ag Substituierte Oxadiaminobutane
FR2639942B1 (fr) * 1988-12-02 1991-03-29 Sanofi Sa Ethers oximes de propenone, procede pour leur preparation et compositions pharmaceutiques les contenant
HUT54347A (en) * 1989-01-10 1991-02-28 Chinoin Gyogyszer Es Vegyeszet Improved process for producing amidoximes

Also Published As

Publication number Publication date
HUT54110A (en) 1991-01-28
US5328906A (en) 1994-07-12
NO178148C (no) 1996-01-31
WO1990004584A1 (en) 1990-05-03
DK149790A (da) 1990-06-19
IL92000A (en) 1994-06-24
US5147879A (en) 1992-09-15
HU207988B (en) 1993-07-28
PT92041B (pt) 1995-07-18
PL164547B1 (pl) 1994-08-31
EP0417210B1 (de) 1994-03-09
US5296606A (en) 1994-03-22
PT92041A (pt) 1990-04-30
ES2020030A6 (es) 1991-07-16
AU4418689A (en) 1990-05-14
UA34412C2 (uk) 2001-03-15
NO178148B (no) 1995-10-23
JPH03502931A (ja) 1991-07-04
CA2000830A1 (en) 1990-04-20
KR900701741A (ko) 1990-12-04
FI93214B (fi) 1994-11-30
FI903075A0 (fi) 1990-06-19
KR0154117B1 (ko) 1998-12-01
NO902703D0 (no) 1990-06-18
IE65113B1 (en) 1995-10-04
IE893364L (en) 1990-04-20
DK149790D0 (da) 1990-06-19
CA2000830C (en) 1997-09-16
GR1002253B (en) 1996-04-23
RU2093508C1 (ru) 1997-10-20
NO902703L (no) 1990-06-18
GR890100669A (el) 1990-11-29
AU620460B2 (en) 1992-02-20
FI93214C (fi) 1995-03-10
DK175584B1 (da) 2004-12-13
JPH0819078B2 (ja) 1996-02-28
IL92000A0 (en) 1990-07-12
DE68913737T2 (de) 1994-07-28
EP0417210A1 (de) 1991-03-20

Similar Documents

Publication Publication Date Title
DE68913737D1 (de) Neue o-(3-amino-2-hydroxypropyl)-hydroximsäurehalogenide und verfahren zur herstellung derselben.
DE68926642D1 (de) Alkalische batterien und verfahren zur herstellung
ATA523481A (de) Ausweiskarte und verfahren zur herstellung derselben
DE3688093D1 (de) Durchsichtiger gegenstand und verfahren zu seiner herstellung.
DE3650563D1 (de) Statistisches Mischpolymer und Verfahren zur Herstellung derselben
DE69230032D1 (de) Polyhydroxycarbonsäure und verfahren zu ihrer herstellung
DE3676393D1 (de) Blasfolie und verfahren und vorrichtung zur herstellung derselben.
DE3878110D1 (de) Zusammengesetztes magnetisches material und verfahren zu seiner herstellung.
DE3774333D1 (de) Dauermagnet-material und verfahren zur herstellung.
DE3579641D1 (de) Verfahren und vorrichtung zur kontinuierlichen herstellung von alkoxypolysiloxanen.
DE3686444D1 (de) N-fluorpyridiniumsalz und verfahren zur herstellung.
PT80637A (de) Saatgupellets und verfahren zur herstellung von solchen
DE68925350D1 (de) Supraleitendes oxidmaterial und verfahren zur herstellung
DE3680216D1 (de) Titandioxidteilchen und verfahren zu ihrer herstellung.
DE3681946D1 (de) Zahnfaeuleschutzpraeparate und verfahren zur herstellung derselben.
DE69332117D1 (de) 4-diphenylmethylpiperidine und verfahren zu ihrer herstellung
DE3685304D1 (de) Drucktuch und verfahren zur herstellung.
DE69102275D1 (de) Alumina enthaltende säureadsorbentien und verfahren zur herstellung derselben.
DE3881765D1 (de) Schaltanzeige und verfahren zu deren herstellung.
DE3776364D1 (de) Dauermagnet und verfahren zur herstellung.
DE3684511D1 (de) Verfahren zur herstellung von l-threonin und l-isoleucin.
DE3684632D1 (de) Tonerzusammensetzung und verfahren zur herstellung.
DE3861820D1 (de) Carbonsaeuren und verfahren zur herstellung derselben.
DE3671246D1 (de) Verfahren zur herstellung von 4-androsten-3,17-dion und 1,4-androstadien-3,17-dion.
DE3675633D1 (de) Geraet und verfahren zur herstellung von steckverbindern.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: BIOREX RT, BUDAPEST, HU

8327 Change in the person/name/address of the patent owner

Owner name: CYTRX CORP., LOS ANGELES, CALIF., US